✦ LIBER ✦

IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study

✍ Scribed by J. Walther; W. Wilmanns; H. H. Gerhartz

Publisher: Springer
Year: 1993
Tongue: English
Weight: 205 KB
Volume: 66
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01697623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating non-cross-resistant chemothe

Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study

✍ Masatni Hirano; Masataka Okamoto; Fumio Maruyama; Kohji Ezaki; Kazuyuki Shimizu; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

A pilot study of cyclical chemotherapy w

A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL)

✍ J. A. Child; D. L. Barnard; S. C. Cartwright; I. Lauder; A. V. Simmons; J. Stone 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 622 KB

CAVBP/DEP alternating chemotherapy for t

CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: Final results of a pilot study

✍ Giovannella Palmieri; Dr. Francesco Caponigro; Rosario Vincenzo Iaffaioli; Alma 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Between May 1984 and September 1986, 40 patients with intermediate or high grade non Hodgkin's lymphoma were treated with a novel protocol, which alternated a conventional regimen consisting of cyclophosphamide, doxorubicin, vincristine, bleomycin, and prednisone (CAVBP) with a second chemotherapy r

Combined chemotherapy with carmustine, d

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma : A long-term follow-up study

✍ Luigi Rigacci; Valentina Carrai; Luca Nassi; Renato Alterini; Giovanni Longo; Fr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views